Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions—Part II: Combination Therapy
Authors:
Open Access
- 1 February 2024
- journal article
- review article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 21 (2) , 115-130
Abstract
Purpose of Review: Fluid retention or congestion is a major cause of symptoms, poor quality of life, and adverse outcome in patients with heart failure (HF). Despite advances in disease-modifying therapy, the mainstay of treatment for congestion—loop diuretics—has remained largely unchanged for 50 years. In these two articles (part I: loop diuretics and part II: combination therapy), we will review the history of diuretic treatment and current trial evidence for different diuretic strategies and explore potential future directions of research. Recent Findings: We will assess recent trials, including DOSE, TRANSFORM, ADVOR, CLOROTIC, OSPREY-AHF, and PUSH-AHF, and assess how these may influence current practice and future research. Summary: There are few data on which to base diuretic therapy in clinical practice. The most robust evidence is for high-dose loop diuretic treatment over low-dose treatment for patients admitted to hospital with HF, yet this is not reflected in guidelines. There is an urgent need for more and better research on different diuretic strategies in patients with HF.Keywords
This publication has 91 references indexed in Scilit:
- Prednisone in Uric Acid Lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) StudyCanadian Journal of Cardiology, 2013
- Ultrafiltration in Decompensated Heart Failure with Cardiorenal SyndromeNew England Journal of Medicine, 2012
- Diuretic Strategies in Patients with Acute Decompensated Heart FailureNew England Journal of Medicine, 2011
- Inhibition of Dehydration-Induced Water Intake by Glucocorticoids Is Associated with Activation of Hypothalamic Natriuretic Peptide Receptor-A in RatPLOS ONE, 2010
- Combination of Loop Diuretics With Thiazide-Type Diuretics in Heart FailureJACC, 2010
- Therapeutic manipulation of glucocorticoid metabolism in cardiovascular diseaseBritish Journal of Pharmacology, 2009
- Glucocorticoids and Cardiovascular DiseaseEuropean Journal of Endocrinology, 2007
- Effects of three sodium-potassium adenosine triphosphatase inhibitors.Hypertension, 1991
- Gluco- and mineralocorticoids may regulate the natriuretic effect and the synthesis and release of atrial natriuretic factor by the rat atria in vivoBiochemical and Biophysical Research Communications, 1985
- A New Effective Diuretic—LasixBMJ, 1964